The World's Leading CDMO
Meet the strategic CDMO partner connecting early development decisions to commercial success at BIO International 2026.
- Any phase
- Any scale
- Across technologies
- Across the globe
DNA-to-IND in as little as 6 months*
You don’t have to trade speed or performance for reliability. With the right partner, you can move faster without setbacks.
- Comprehensive candidate selection and optimization
- High-performing cell line, delivering titers up to 11 g/L and powering 100+ molecules to market
- Tox material supply in as little as 2 months
- Lean process, analytical and formulation development
- Robust, proven platform processes
- Integrated drug substance and drug product programs, for any molecule type
- 100% IND-enabling success rate for 30+ years.
Discover the integrated DNA-to-IND solution for your program.
* From DNA transfection to delivery of IND-enabling CMC modules. Typical timelines for mAbs. Subject to terms and conditions.
Built for commercial scale and secure supply
When supply security matters most, one partner is all you need. With the largest mammalian manufacturing capacity in the US, a globally diversified footprint, and a 100% success rate across CMC dossier sections, we deliver the scale, technology, and regional reach your program demands.
Backed by 40+ years of CDMO expertise and 80+ commercial launches, we're built to support your biologics from today's needs to tomorrow's ambitions.
Learn more about end-to-end biologics manufacturing.
Start the conversation
Our team is ready to talk through your project.
Complete the form to book your meeting at Booth #4735, and our team will be in touch.
Contact information
We will use your details to better assist you.
Thank you for your submission!
We appreciate you contacting us. One of our colleagues will get back in touch with you soon!
Our Offering
Related Insights
